e8vk
Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

     
     Date of report (Date of earliest event reported)
  October 29, 2004
 
 

Safeguard Scientifics, Inc.


(Exact Name of Registrant as Specified in Its Charter)

Pennsylvania


(State or Other Jurisdiction of Incorporation)
     
1-5620   23-1609753

 
(Commission File Number)   (IRS Employer Identification No.)
     
800 The Safeguard Building    
435 Devon Park Drive    
Wayne, PA   19087

 
(Address of Principal Executive Offices)   (Zip Code)

610-293-0600


(Registrant’s Telephone Number, Including Area Code)

Not applicable


(Former Name or Former Address, if Changed Since Last Report)

     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



 


TABLE OF CONTENTS

ITEM 2.02. Results of Operations and Financial Condition
ITEM 9.01. Financial Statements and Exhibits
SIGNATURES
Exhibit Index
PRESS RELEASE


Table of Contents

ITEM 2.02. Results of Operations and Financial Condition

     On October 29, 2004, Safeguard Scientifics, Inc. (“Safeguard”) issued a press release setting forth Safeguard’s financial information for the third quarter ended September 30, 2004. A copy of Safeguard’s press release is attached hereto as Exhibit 99.1 and hereby incorporated by reference.

     This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”) or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

ITEM 9.01. Financial Statements and Exhibits

     (c) Exhibits

     
99.1
  Press Release of Safeguard Scientifics, Inc. dated October 29, 2004.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
  Safeguard Scientifics, Inc.
 
 
Dated: October 29, 2004  By:   CHRISTOPHER J. DAVIS    
    Christopher J. Davis   
    Executive Vice President and Chief Administrative & Financial Officer   

 


Table of Contents

         

Exhibit Index

     
99.1
  Press release of Safeguard Scientifics, Inc. dated October 29, 2004.